The Georgia Tech Research Corp. provides research and technology support services. Its services include accounting and reports, researcher and operational support services. The comapny was founded by Preston S. Arkwright, Fuller E. Callaway, Jr. and Monie A. Ferst on April 13, 1937 and is headquartered in Atlanta, GA.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Meito Sangyo Co., Ltd. engages in the manufacture and sale of food and chemical products. It operates through the following segments: Food, Chemicals, and Real Estate. The Food segment engages in the manufacture and sale of chocolate, candy, ice cream, jelly, powdered juice, and canned drinks. The Chemicals segment engages in the manufacture and sale of pharmaceutical products and enzymes. The Real Estate segment covers golf course operations and real estate leasing business. The company was founded on February 8, 1945 and is headquartered in Nagoya, Japan.

Future Medicine Co., Ltd. engages in providing drug development services in the areas of anti- inflammation, fibrosis, anti virus and anti cancer. The company was founded on June 4, 2015 and is headquartered in Seongnam-si, South Korea.

Daiichi Pharmaceutical Co. Ltd. manufactured pharmaceutical products. It used to make prescription drugs, OTC treatments and animal health products. The firm's prescription drugs included treatments for allergies, hypertension and stroke; it also has drugs in clinical trials. It was founded in 1915 and was located in Tokyo, Japan.

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Topas Therapeutics GmbH is a private Hamburg, Germany-based biotechnology company focused on developing products to address areas of major unmet need, including autoimmune diseases, allergies and anti-drug antibodies. The Topas Particle Conjugates technology platform induces antigen-specific immune tolerance by harnessing the liver’s natural immunology capabilities. The Company has several proprietary programs; lead product candidate TPM203 has recently entered clinical testing for pemphigus vulgaris, an orphan disease. Other programs are in anti-drug antibodies, celiac disease, Type 1 diabetes, as well as a multiple sclerosis program that is available for partnering. Topas has a research and option agreement with Eli Lilly and Company focused on antigen-specific tolerance induction and a multi-year agreement with Boehringer Ingelheim to collaborate in the field of anti-drug antibodies. Topas’ investors include: Epidarex Capital, Gimv, EMBL Ventures, Evotec and Boehringer Ingelheim Venture Fund.

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products. The Pharmaceutical related segment involves the manufacture and sale of injections, oral agents, and pharmaceutical kit products. The Pharma Packaging segment provides glass products for bottle tubes, ampoules, thermos-use, and lighting. The Others segment includes real estate leasing. The company was founded on July 8, 1954 and is headquartered in Osaka, Japan.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Universitätsklinikum Hamburg-Eppendorf operates as a university hospital. It offers basic and specialized healthcare services, and it offers medical students an opportunity to practice their profession. The hospital was founded on the 19th of May, 1889 and is located in Hamburg, Germany.

Kolmar BNH is a domestic health functional food and cosmetics market by researching and developing new materials based on natural products.

Jiangsu Saigu Cell Engineering Research Institute Co., Ltd., established on 2018-05-31, Business scope includes pharmaceutical research and development and technical services,technology transfer,technical consulting;cell engineering,bioengineering development;Biotechnology,Cell Technology Development,technology transfer;Research and development of biological experiment reagents,Sales;biology,pharmaceutical products,Medical device technology development and technology transfer,technical consulting,Technical Services;Business Management Consulting;Experimental equipment and consumables,biological reagent,Sales of Medical Devices;medicine,Medical device production;Cell Valley Construction Management;Public technology platform operation and management;gene technology,Research and development of technologies and new medicines in the field of biotechnology,technical consulting,Technical Services,technology transfer;Experimental instrument sales,Experimental equipment rental;Own house rental;property management;accommodation service;Conference and Exhibition Consulting Services;Testing service;Transformation service of scientific and technological achievements;Science and Technology Enterprise Cultivation Service;Mergers and acquisitions and restructuring services for technology companies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);R&D and application of cell technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Daiichi Seiyaku Co., Ltd. engaged in the manufacture, sale research and development of medicine. The company was founded on October 1, 1915 and was headquartered in Tokyo, Japan.